What is the recommended management for an acute exacerbation of bronchial asthma?

Management of Acute Asthma Exacerbation

Immediately administer oxygen to maintain SpO2 >90% (>95% in pregnancy/cardiac disease), give inhaled short-acting beta-2 agonists (albuterol 2.5-5 mg nebulized or 4-8 puffs via MDI every 20 minutes for 3 doses), add ipratropium bromide 0.5 mg nebulized every 20 minutes for 3 doses, and start systemic corticosteroids (prednisone 40-80 mg/day or equivalent) within the first hour 1.

Initial Assessment and Severity Stratification

Rapidly assess severity through:

• Oxygen saturation (SpO2 <90% indicates severe exacerbation)
• Peak expiratory flow (PEF) or FEV1 if available (<40% predicted = severe; <25% predicted = life-threatening)
• Ability to speak (speaking in words rather than sentences = severe)
• Respiratory rate, heart rate, use of accessory muscles
• Mental status changes (confusion/drowsiness = impending respiratory failure)

Patients with FEV1 or PEF ≤25% predicted after initial treatment, severe distress, or altered mental status require intensive monitoring and possible ICU transfer 1.

First-Line Treatment (All Patients)

1. Oxygen Therapy

Administer via nasal cannula or mask to maintain SpO2 >90% (>95% in pregnant patients or those with heart disease). Continue monitoring until clear response to bronchodilators occurs 1.

2. Inhaled Short-Acting Beta-2 Agonists

• Albuterol nebulizer: 2.5-5 mg every 20 minutes for 3 doses initially
• Albuterol MDI: 4-8 puffs every 20 minutes for up to 4 hours
• After initial 3 doses, continue every 1-4 hours based on response
• For severe exacerbations (PEF/FEV1 <40% predicted): Consider continuous nebulization at 10-15 mg/hour 1

Approximately 60-70% of patients respond sufficiently to the initial 3 doses for discharge consideration 1.

3. Anticholinergics (Add for Moderate-to-Severe Exacerbations)

• Ipratropium bromide: 0.5 mg nebulized every 20 minutes for 3 doses, then as needed
• Combination ipratropium/albuterol: 3 mL every 20 minutes for 3 doses
• Can be mixed in same nebulizer with albuterol
• Critical caveat: Adding ipratropium provides no additional benefit once the patient is hospitalized, so use primarily in ED setting 1

4. Systemic Corticosteroids (Most Patients)

• Prednisone/prednisolone/methylprednisolone: 40-80 mg/day in 1-2 divided doses until PEF reaches 70% of predicted or personal best
• Start early—speeds resolution of airflow obstruction 1
• No advantage to IV administration over oral in most cases 1
• No advantage to higher doses in severe exacerbations 1

Second-Line Treatment (Severe Exacerbations Not Responding to First-Line)

Intravenous Magnesium Sulfate

Consider for patients with severe exacerbations (FEV1/PEF <40% predicted) who fail to respond adequately to initial bronchodilator therapy 2, 3.

Heliox-Driven Nebulization

May be considered for severe and very severe exacerbations as adjunctive therapy 3.

Third-Line Treatment (Life-Threatening/ICU-Level Care)

Aminophylline

Reserved as third-line for poorly responding patients 2.

Subcutaneous Epinephrine or Terbutaline

• Epinephrine 1:1000: 0.3-0.5 mg subcutaneously every 20 minutes for 3 doses
• Terbutaline: 0.25 mg subcutaneously every 20 minutes for 3 doses
• Important limitation: No proven advantage over inhaled therapy 1

Monitoring and Reassessment

• Reassess every 20-30 minutes during initial treatment phase
• Monitor SpO2 continuously until clear response
• Repeat PEF or FEV1 measurements after each treatment cycle
• Assess for signs of respiratory failure requiring intubation

Disposition Criteria

Discharge Home (After 4 Hours Observation)

• PEF >70% predicted or personal best
• Sustained response to bronchodilators (no deterioration for 60 minutes after last treatment)
• SpO2 >90% on room air
• Adequate home support and follow-up arranged

Hospital Admission Required

• Incomplete response to treatment after 1-2 hours
• PEF <70% predicted after treatment
• High-risk patients (prior intubation, recent hospitalization, overuse of SABA >1 canister/month, psychiatric illness, poor adherence) 4

ICU Transfer Indications

• Severe exacerbation unresponsive to first-line treatment
• Impending or actual respiratory failure
• Altered mental status, exhaustion
• PaCO2 rising or >45 mmHg with respiratory acidosis

Critical Pitfalls to Avoid

1. Do not use SABA alone without ICS-containing therapy for discharge prescriptions 5
2. Do not delay systemic corticosteroids—they should be given within the first hour 1
3. Do not continue ipratropium after hospital admission—no additional benefit 1
4. Do not routinely order chest X-rays unless suspecting pneumonia, pneumothorax, or heart failure 1
5. Antibiotics are NOT indicated unless definite bacterial infection present 2

Discharge Planning

Patients discharged must receive:

• 5-10 day course of oral corticosteroids (prednisone 40-60 mg daily for adults)
• ICS-containing maintenance therapy (preferably ICS-formoterol as both controller and reliever) 5
• Written asthma action plan
• Scheduled follow-up within 2-4 weeks 4
• Inhaler technique education and verification